SEMplMe: a tool for integrating DNA methylation effects in transcription factor binding affinity predictions

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Motivation: Aberrant DNA methylation in transcription factor binding sites has been shown to lead to anomalous gene regulation that is strongly associated with human disease. However, the majority of methylation-sensitive positions within transcription factor binding sites remain unknown. Here we introduce SEMplMe, a computational tool to generate predictions of the effect of methylation on transcription factor binding strength in every position within a transcription factor’s motif. Results: SEMplMe uses ChIP-seq and whole genome bisulfite sequencing to predict effects of methylation within binding sites. SEMplMe validates known methylation sensitive and insensitive positions within a binding motif, identifies cell type specific transcription factor binding driven by methylation, and outperforms SELEX-based predictions for CTCF. These predictions can be used to identify aberrant sites of DNA methylation contributing to human disease. Availability and Implementation: SEMplMe is available from https://github.com/Boyle-Lab/SEMplMe.

Cite

CITATION STYLE

APA

Nishizaki, S. S., & Boyle, A. P. (2022). SEMplMe: a tool for integrating DNA methylation effects in transcription factor binding affinity predictions. BMC Bioinformatics, 23(1). https://doi.org/10.1186/s12859-022-04865-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free